{"id":10231,"date":"2026-07-15T10:31:55","date_gmt":"2026-07-15T08:31:55","guid":{"rendered":"https:\/\/cleanpeptides.eu\/selank-doseringsguide\/"},"modified":"2026-07-15T10:31:55","modified_gmt":"2026-07-15T08:31:55","slug":"selank-doseringsguide","status":"publish","type":"page","link":"https:\/\/cleanpeptides.eu\/da\/selank-doseringsguide\/","title":{"rendered":"Selank doseringsguide: intranasal, subkutan og kure"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><em>Anxiolytisk nootropisk peptid \u2014 intranasal og subkutan dosering, BDNF-opregulering, kombination med Semax, cyklus og sikkerhed. Kun til forskningsform\u00e5l \u2014 ikke til human brug.<\/em><\/p>\n<p class=\"wp-block-paragraph\">Clean Peptides giver ikke r\u00e5dgivning om dosering eller anvendelse. Denne guide samler produktinformation fra Clean Peptides sammen med uafh\u00e6ngigt undervisningsmateriale fra PeptideWiki, kun som forskningsreference. Det er ikke medicinsk r\u00e5dgivning og udg\u00f8r hverken anbefalinger, godkendelser eller instruktioner fra Clean Peptides.<\/p>\n<h2 class=\"wp-block-heading\">Hvad er Selank?<\/h2>\n<p class=\"wp-block-paragraph\">Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) er et syntetisk heptapeptid udviklet p\u00e5 Institut for Molekyl\u00e6r Genetik ved det Russiske Videnskabsakademi \u2014 en stabiliseret analog af det immunregulerende tetrapeptid tuftsin. Det er b\u00e5de anxiolytisk og nootropisk: det modulerer GABA, serotonin, dopamin og noradrenalin og giver angstd\u00e6mpende effekter, der kan sammenlignes med benzodiazepiner i lav dosis, men uden sedation, kognitiv sv\u00e6kkelse, tolerance eller afh\u00e6ngighed. Det \u00f8ger ogs\u00e5 BDNF-ekspressionen. Selank er et godkendt receptpligtigt anxiolytikum i Rusland (0,15 % n\u00e6sespray).<\/p>\n<p class=\"wp-block-paragraph\">Doseringen stammer fra russiske kliniske data, publiceret forskning og protokoller fra f\u00e6llesskabet.<\/p>\n<h2 class=\"wp-block-heading\">N\u00f8gleegenskaber<\/h2>\n<ul class=\"wp-block-list\">\n<li>Anxiolytisk nootropikum \u2014 angstreduktion uden sedation eller afh\u00e6ngighed.<\/li>\n<li>Heptapeptid \u2014 tuftsin-analog med en Pro-Gly-Pro-forl\u00e6ngelse.<\/li>\n<li>Multisystemmodulation \u2014 GABA, serotonin, dopamin, noradrenalin.<\/li>\n<li>BDNF-opregulering \u2014 underst\u00f8tter neuroplasticitet og hukommelse.<\/li>\n<li>Immunmodulerende \u2014 modulerer IL-6- og interferonveje.<\/li>\n<li>Ingen afh\u00e6ngighed eller abstinenser \u2014 i mods\u00e6tning til benzodiazepiner.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">S\u00e5dan fastl\u00e6gges doseringen<\/h2>\n<p class=\"wp-block-paragraph\">Det godkendte russiske produkt leverer 75 mcg pr. spray; standardregime 2\u20133 spray pr. n\u00e6sebor 3\u00d7 dagligt (900\u20131350 mcg\/dag), 14-dages kure. Pr\u00e6kliniske anxiolytiske effekter ved 100\u2013500 mcg\/kg; BDNF-opregulering efter 5\u20137 dages gentagen dosering. Evidensstyrke: moderat til st\u00e6rk for et forskningspeptid.<\/p>\n<h2 class=\"wp-block-heading\">Standarddoseringsintervaller<\/h2>\n<h3 class=\"wp-block-heading\">Intranasal<\/h3>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Niveau<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Dosis<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Hyppighed<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Dagligt total<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Begynder<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">200\u2013250 mcg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u20132\u00d7 dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">200\u2013500 mcg<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Mellem<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">250\u2013500 mcg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2\u20133\u00d7 dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">500\u20131500 mcg<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Avanceret<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">500 mcg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">3\u00d7 dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1500 mcg<\/td>\n<\/tr>\n<\/table>\n<h3 class=\"wp-block-heading\">Subkutan<\/h3>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Niveau<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Dosis<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Hyppighed<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Dagligt total<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Begynder<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">100 mcg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u00d7 dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">100 mcg<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Mellem<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">200 mcg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u20132\u00d7 dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">200\u2013400 mcg<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Avanceret<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">250\u2013300 mcg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u20132\u00d7 dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">250\u2013600 mcg<\/td>\n<\/tr>\n<\/table>\n<h3 class=\"wp-block-heading\">Intranasal vs subkutan<\/h3>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Parameter<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Intranasal<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Subkutan<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Biotilg\u00e6ngelighed<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Moderat (n\u00e6seslimhinde)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">H\u00f8jere (systemisk)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">CNS-adgang<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Direkte via lugtebanen<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Indirekte (krydser BBB)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Inds\u00e6ttelse<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">10\u201330 min<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">15\u201345 min<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Typisk dosis<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">250\u2013500 mcg, 1\u20133\u00d7 dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">100\u2013300 mcg, 1\u20132\u00d7 dagligt<\/td>\n<\/tr>\n<\/table>\n<h2 class=\"wp-block-heading\">Rekonstituering og dosering (med de medf\u00f8lgende 3 mL)<\/h2>\n<p class=\"wp-block-paragraph\">Hvert Clean Peptides-h\u00e6tteglas leveres med 3 mL bakteriostatisk vand (0,9 % benzylalkohol). Alle tal nedenfor foruds\u00e6tter rekonstituering med de fulde 3 mL. P\u00e5 en standard U-100-insulinspr\u00f8jte er 100 enheder = 1 mL. Hurtig formel: koncentration = h\u00e6tteglasstyrke \u00f7 3 mL, og enheder at tr\u00e6kke op = dosis (mg) \u00d7 300 \u00f7 h\u00e6tteglasstyrke (mg). Til intranasal brug kan den rekonstituerede v\u00e6ske overf\u00f8res til en sprayflaske.<\/p>\n<h3 class=\"wp-block-heading\">S\u00e5dan rekonstitueres<\/h3>\n<ol class=\"wp-block-list\">\n<li>Vask h\u00e6nderne og l\u00e6g h\u00e6tteglasset, de 3 mL bakteriostatisk vand, en insulinspr\u00f8jte og spritservietter frem p\u00e5 en ren overflade.<\/li>\n<li>Vip h\u00e6tterne af og aft\u00f8r begge gummipropper med sprit; lad dem luftt\u00f8rre 10\u201315 sekunder.<\/li>\n<li>Tr\u00e6k de fulde 3 mL bakteriostatisk vand op (i tre 1 mL-omgange med en insulinspr\u00f8jte eller i \u00e9n omgang med en 3 mL-spr\u00f8jte).<\/li>\n<li>Tils\u00e6t vandet langsomt, og vinkl n\u00e5len, s\u00e5 det l\u00f8ber ned ad den indvendige glasv\u00e6g \u2014 spr\u00f8jt det aldrig direkte p\u00e5 pulveret.<\/li>\n<li>Opl\u00f8s forsigtigt \u2014 lad h\u00e6tteglasset st\u00e5 1\u20132 minutter, og hvirvl eller rul det derefter mellem h\u00e5ndfladerne, til opl\u00f8sningen er klar. Ryst aldrig.<\/li>\n<li>M\u00e6rk og opbevar i k\u00f8leskab ved 2\u20138 \u00b0C. Resulterende koncentration: 5 mg \u2192 1,67 mg\/mL; 10 mg \u2192 3,33 mg\/mL.<\/li>\n<\/ol>\n<p class=\"wp-block-paragraph\"><strong>Opbevaring:<\/strong> ikke-rekonstitueret pulver i k\u00f8leskab (2\u20138 \u00b0C); rekonstitueret opl\u00f8sning i k\u00f8leskab og anvendt inden for 28\u201330 dage; m\u00e5 ikke fryses; beskyt mod lys og varme.<\/p>\n<h3 class=\"wp-block-heading\">Optr\u00e6ksvolumener med 3 mL \u2014 Selank<\/h3>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">H\u00e6tteglas (Clean Peptides)<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Koncentration<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">100 mcg<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">200 mcg<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">300 mcg<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">5 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1,67 mg\/mL<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">6 e<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">12 e<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">18 e<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">10 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">3,33 mg\/mL<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">3 e<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">6 e<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">9 e<\/td>\n<\/tr>\n<\/table>\n<h2 class=\"wp-block-heading\">Dosering efter m\u00e5l<\/h2>\n<ul class=\"wp-block-list\">\n<li><strong>Angstreduktion:<\/strong> 250\u2013500 mcg intranasalt eller 150\u2013250 mcg SC, 2\u20133\u00d7 dagligt; 2\u20134 ugers brug, 1\u20132 ugers pause. Akut lindring inden for 10\u201330 min.<\/li>\n<li><strong>Kognitiv forbedring \/ BDNF:<\/strong> 250\u2013400 mcg intranasalt eller 150\u2013200 mcg SC, 2\u00d7 dagligt; 3\u20134 ugers brug, 1\u20132 ugers pause. Kombin\u00e9r med Semax.<\/li>\n<li><strong>Immunmodulation og restitution:<\/strong> 250\u2013500 mcg intranasalt eller 200\u2013300 mcg SC, 1\u20132\u00d7 dagligt; 2\u20133 ugers brug, 1 uges pause.<\/li>\n<li><strong>Neurobeskyttelse og hjernesundhed:<\/strong> 200\u2013300 mcg intranasalt eller 100\u2013200 mcg SC, 1\u20132\u00d7 dagligt; 4 ugers brug, 2 ugers pause.<\/li>\n<\/ul>\n<p class=\"wp-block-paragraph\">Konsekvens betyder mere end topdosis \u2014 BDNF-effekter er kumulative over dage til uger.<\/p>\n<h2 class=\"wp-block-heading\">Cyklusprotokoller<\/h2>\n<p class=\"wp-block-paragraph\">Ingen rapporteret tolerance, afh\u00e6ngighed eller abstinenser; cyklus anbefales som bedste praksis.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Protokol<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">I kur<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Uden for kur<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Russisk farmaceutisk<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">14 dage<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">14 dages pause<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Standardforskning<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">3\u20134 uger<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u20132 ugers pause<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Forl\u00e6nget<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">6\u20138 uger<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2\u20133 ugers pause<\/td>\n<\/tr>\n<\/table>\n<p class=\"wp-block-paragraph\">Ingen nedtrapning n\u00f8dvendig ved oph\u00f8r.<\/p>\n<h2 class=\"wp-block-heading\">Kombinationsprotokoller<\/h2>\n<p class=\"wp-block-paragraph\"><strong>Selank + Semax \u2014 den russiske nootropiske kombination (guldstandard):<\/strong> Selank 250\u2013500 mcg + Semax 200\u2013600 mcg, intranasalt 2\u20133\u00d7 dagligt. Selank opregulerer BDNF; Semax opregulerer BDNF + NGF.<\/p>\n<p class=\"wp-block-paragraph\">Fulde Semax-protokoller: se vores <a href=\"https:\/\/cleanpeptides.eu\/da\/semax-doseringsguide\/\">Semax-doseringsguide<\/a>. Andre kombinationer: Selank + BPC-157 (neuro-tarm-akse); Selank + NA-Selank (hurtig + forl\u00e6nget d\u00e6kning); Selank + Semax + BPC-157 (fuld neuropeptidkombination).<\/p>\n<h2 class=\"wp-block-heading\">Sikkerhed, bivirkninger og kontraindikationer<\/h2>\n<p class=\"wp-block-paragraph\">En af de mest gunstige sikkerhedsprofiler blandt forskningspeptider; ingen tolerance, afh\u00e6ngighed eller abstinenser.<\/p>\n<p class=\"wp-block-paragraph\"><strong>Milde, sj\u00e6ldne:<\/strong> n\u00e6seirritation\/svien (intranasal), let tr\u00e6thed ved h\u00f8jere doser, lejlighedsvis hovedpine, milde smags-\/lugt\u00e6ndringer. <strong>Sj\u00e6ldne:<\/strong> irritation ved injektionsstedet, let svimmelhed, allergiske reaktioner.<\/p>\n<p class=\"wp-block-paragraph\"><strong>Kontraindikationer:<\/strong> graviditet og amning; kendt allergi over for Selank\/tuftsin; forsigtighed ved autoimmune tilstande; forsigtighed med st\u00e6rke GABAerge l\u00e6gemidler; aktiv n\u00e6seinfektion\/sv\u00e6re polypper (intranasal vej).<\/p>\n<p class=\"wp-block-paragraph\">Godkendt i Rusland; ikke FDA\/EMA-godkendt; forskningspeptid i de fleste vestlige lande.<\/p>\n<h2 class=\"wp-block-heading\">Almindelige fejl<\/h2>\n<ul class=\"wp-block-list\">\n<li>Forkert intranasal teknik (spray mod skillev\u00e6ggen, kraftig sn\u00f8ften, at pudse n\u00e6se bagefter).<\/li>\n<li>At forvente \u00f8jeblikkelige langsigtede kognitive effekter (BDNF-fordele opbygges over 1\u20132 uger).<\/li>\n<li>At opbevare rekonstitueret Selank ved stuetemperatur.<\/li>\n<li>At bruge for h\u00f8je doser (fladt dosis-respons over ~500 mcg intranasalt).<\/li>\n<li>At forveksle Selank-dosering med NA-Selank.<\/li>\n<li>Ikke at opretholde konsekvent daglig dosering.<\/li>\n<li>At fors\u00f8mme n\u00e6sehygiejne ved intranasal brug.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Hovedpunkter<\/h2>\n<ul class=\"wp-block-list\">\n<li>Anxiolytisk nootropikum \u2014 angstlindring uden sedation eller afh\u00e6ngighed.<\/li>\n<li>250\u2013500 mcg intranasalt 1\u20133\u00d7 dagligt, eller 100\u2013300 mcg SC.<\/li>\n<li>Intranasal vej foretrukket (hurtig inds\u00e6ttelse, direkte CNS-adgang).<\/li>\n<li>BDNF-opregulering er kumulativ over 1\u20132 uger.<\/li>\n<li>Guldstandard-kombination: Selank + Semax. Ingen tolerance\/abstinenser; godkendt i Rusland, ikke FDA-godkendt.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Referencer<\/h2>\n<ol class=\"wp-block-list\">\n<li>Seredenin SB, et al. &#8220;Anxiolytic effect of peptide preparation Selank.&#8221; Bull Exp Biol Med. 1998;126(1):643-645.<\/li>\n<li>Kozlovskaya MM, et al. &#8220;Anxiolytic-like and nootropic effects of Selank.&#8221; Vestn Ross Akad Med Nauk. 2002;(8):36-40.<\/li>\n<li>Zozulya AA, et al. &#8220;Inhibitory effect of Selank on enkephalin-degrading enzymes.&#8221; Bull Exp Biol Med. 2001;131(4):315-317.<\/li>\n<li>Ershov FI, et al. &#8220;Antiviral activity of immunomodulatory peptide Selank.&#8221; Bull Exp Biol Med. 2009;148(3):426-429.<\/li>\n<li>Volkova A, et al. &#8220;Selank affects genes involved in GABAergic neurotransmission.&#8221; Front Pharmacol. 2016;7:31.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Download og relaterede ressourcer<\/h2>\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/cleanpeptides.eu\/wp-content\/uploads\/2026\/07\/06-Selank-Dosage-Guide-Clean-Peptides.pdf\" target=\"_blank\" rel=\"noopener\">\ud83d\udcc4 Download den fulde PDF-guide<\/a><\/p>\n<p class=\"wp-block-paragraph\">K\u00f8b Selank: <a href=\"https:\/\/cleanpeptides.eu\/product\/selank-10-mg\/\">Selank 10 mg<\/a> \u00b7 <a href=\"https:\/\/cleanpeptides.eu\/product\/selank-5-mg\/\">Selank 5 mg<\/a>. Relaterede guider: <a href=\"https:\/\/cleanpeptides.eu\/da\/semax-doseringsguide\/\">Semax<\/a> \u00b7 <a href=\"https:\/\/cleanpeptides.eu\/da\/bpc-157-doseringsguide\/\">BPC-157<\/a>.<\/p>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div> \n","protected":false},"excerpt":{"rendered":"<p>Anxiolytisk nootropisk peptid \u2014 intranasal og subkutan dosering, BDNF-opregulering, kombination med Semax, cyklus og sikkerhed. Kun til forskningsform\u00e5l \u2014 ikke [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-10231","page","type-page","status-publish","hentry"],"_hostinger_reach_plugin_has_subscription_block":false,"_hostinger_reach_plugin_is_elementor":false,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages\/10231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/comments?post=10231"}],"version-history":[{"count":0,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages\/10231\/revisions"}],"wp:attachment":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/media?parent=10231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}